Cuprina Holdings Announces Pricing Of $4.97M Public Offering Of 4,322,489 Class A Ordinary Shares At $1.15/Share; Expects Close On Or About September 17

Cuprina Holdings shares are trading lower. The company announced the acquisition of East Coast Podiatry and Orchard Clinic for ~$3.1 million.

Cuprina Holdings To Acquire East Coast Podiatry And Orchard Clinic For ~$3.1M

Cuprina Holdings (Cayman) Limited Announces Closing of Underwriter’s Over-Allotment Option in Connection with Public Offering

Cuprina Holdings (Nasdaq: CUPR), a biomedical company, announced the successful closing of its underwriter's over-allotment option, selling an additional 648,373 Class A ordinary shares at $1.15 per share for approximately $745,629 in gross proceeds. Combined with the initial public offering, the company raised total aggregate gross proceeds of approximately $5.72 million, which will be used for business expansion, R&D activities, market growth, and general corporate purposes.

Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering

Cuprina Holdings (Nasdaq: CUPR), a biomedical company focused on chronic wounds, infertility, medical waste recycling, and cosmeceuticals, closed its public offering of 4.32 million Class A Ordinary Shares at $1.15 per share, raising approximately $4.97 million in gross proceeds. The company plans to use net proceeds for R&D expansion, new market entry, brand building, and infrastructure investment. The offering follows FDA 510(k) clearance for MEDIFLY Maggots™ in June.